Display MoreSome basics about CoV-19:
CoV-19 in a first step is a respiratory tract infection starting point nose/pharynx.
So far we have no vaccine to prevent any upper respiratory tract infection!
Why: Mucosa is directly exposed to air and the antibodies that should protect you usually sit/travel in the blood or in minor concentrations can be found along tissue.
No vaccine ever will prevent the primary infection of nasal mucosa! There are experimental sprays containing antibodies that can give you a "short" time protection - what would be the best solution e.g. for a long distance flight.
Thus the CoV-19 vaccine will not fully protect you but it can certainly help to avoid the live endangering stage 3 of the infection - hopefully with at least 90% guarantee.
Why can/could CoV-19 vaccinated people be potential spreaders? Viral replication in nasal mucosa will always be delivered - at least in a part - to the outside that's towards your friends. After a high direct dose to the lung even a super spreader could be possible.
To make it clear: There are no vaccines and possibly never will be some that can prevent you from a nasal mucosa infection. And as usual: You can contain it many times unless/until the cell's itself start to develop an RNA memory to directly fight the foreign RNA.
Thus flights etc. for vaccinated people only is a primitive try to spread fear and force people into a useless act! The CoV-19 virus will stay for ever as all other corona virus do too. We have to learn to diagnose/treat it early.
Once more: A horse dose of Ivermectin is enough to save your live even if you have preconditions. If you have long lasting COV-19 symptoms then take three standard doses of Ivermectin as recommended by https://covid19criticalcare.com/ to clear the virus!
Well let me add this to my esteemed co-conspiritor Wyttenbach , this little study on vitamin d and colds. I didn't see the authors at the last conspiriacy meeting. Give it a read Jed. Education is important!!!
Self-Care for Common Colds: The Pivotal Role of Vitamin D, Vitamin C, Zinc, and Echinacea in Three Main Immune Interactive Clusters (Physical Barriers, Innate and Adaptive Immunity) Involved during an Episode of Common Colds—Practical Advice on Dosages and on the Time to Take These Nutrients/Botanicals in order to Prevent or Treat Common Colds
https://www.ncbi.nlm.nih.gov/p…s/PMC5949172/#!po=3.19149
Maintaining a normal healthy immune defense system lowers the incidence and/or the severity of symptoms and/or the duration of common cold (CC). Physical barriers and innate and adaptive immunity have been involved during a CC episode. Vitamins C and D, zinc, and Echinacea have evidence-based efficacy on these immune system barriers. This review includes 82 eligible studies to consider the preventive role of these nutrients in immune clusters and in CC to provide advice on dosage and assumption of these nutrients. Regarding vitamin C, regular supplementation (1 to 2 g/day) has shown that vitamin C reduces the duration (in adults by 8%, in children by 14%) and the severity of CC. Considering zinc, the supplementation may shorten the duration of colds by approximately 33%. CC patients may be instructed to try zinc within 24 hours of onset of symptoms. As for vitamin D, the supplementation protected against CC overall, considering baseline levels and age. Patients with vitamin D deficiency and those not receiving bolus doses experienced the most benefit. Regarding Echinacea, prophylactic treatment with this extract (2400 mg/day) over 4 months appeared to be beneficial for preventing/treating CC. In conclusion, the current evidence of efficacy for zinc, vitamins D and C, and Echinacea is so interesting that CC patients may be encouraged to try them for preventing/treating their colds, although further studies are needed on this topic.
1. Introduction
Common cold (CC) is a conventional term used for mild upper